Literature DB >> 572297

Nucleotide sequence coding for the N-terminal region of the matrix protein influenza virus.

G W Both, G M Air.   

Abstract

After polyadenylation in vitro of the influenza virus RNA segment which contains the coding information for the matrix protein, a cDNA copy can be made using the primer p(dT)8-dA and reverse transcriptase. The sequence of 166 nucleotides of the cDNA was determined by a modification [Brownlee, G. G. & Cartwright, E. M. (1977) J. Mol. Biol, 114, 93--117] of the plus/minus method [Sanger, F. & Coulson, A. R. (1975) J. Mol. Biol. 94, 441--481] and adaptation of the "dideoxy" method [Sanger, F., Nicklen, S. & Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U.S.A. 74, 5463--5467] for sequencing DNA. The cDNA sequences is of the same sense as the mRNA for matrix protein and contains a potential initiating codon, d(ATG), at position 26--28. When matrix protein purified from virus particles was digested with chymotrypsin or trypsin and the amino acid compositions of separated peptides determined, one peptide containing nine amino acids found which had a composition corresponding to that predicted by the cDNA sequence following the first methionine codon, confirming that protein synthesis initiates at this position. The compositions of four other peptides matches those predicted from the nucleotide sequence. There is no processing of the N terminus of the protein before incorporation into the virus particle except for removal of the N-terminal methionine and addition of a "blocking" group on the resulting N-terminal serine residue.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 572297     DOI: 10.1111/j.1432-1033.1979.tb13048.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  Extensive sequence homology at the 3'-termini of the four RNAs of cucumber mosaic virus.

Authors:  R H Symons
Journal:  Nucleic Acids Res       Date:  1979-10-25       Impact factor: 16.971

2.  Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides.

Authors:  Z P Ye; N W Baylor; R R Wagner
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Antigenic structure and variation in an influenza virus N9 neuraminidase.

Authors:  R G Webster; G M Air; D W Metzger; P M Colman; J N Varghese; A T Baker; W G Laver
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Conservation and variation in the hemagglutinins of Hong Kong subtype influenza viruses during antigenic drift.

Authors:  G W Both; M J Sleigh
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

5.  Structure of the host-derived sequences present at the 5' ends of influenza virus mRNA.

Authors:  A J Caton; J S Robertson
Journal:  Nucleic Acids Res       Date:  1980-06-25       Impact factor: 16.971

6.  Anomalous electrophoretic behavior of the membrane (M) protein of influenza virus in polyacrylamide gels.

Authors:  A Gregoriades; K Markarian
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Variation in nucleotide sequences coding for the N-terminal regions of the matrix and nonstructural proteins of influenza A viruses.

Authors:  R M Hall; G M Air
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

8.  Sequence of DNA complementary to a small RNA segment of influenza virus A/NT/60/68.

Authors:  B A Moss; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

9.  A general strategy for cloning double-stranded RNA: nucleotide sequence of the Simian-11 rotavirus gene 8.

Authors:  G W Both; A R Bellamy; J E Street; L J Siegman
Journal:  Nucleic Acids Res       Date:  1982-11-25       Impact factor: 16.971

10.  Antigenic drift in the hemagglutinin of the Hong Kong influenza subtype: correlation of amino acid changes with alterations in viral antigenicity.

Authors:  M J Sleigh; G W Both; P A Underwood; V J Bender
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.